# Commission Decision of 17 April 2008 on the allocation of quantities of controlled substances allowed for essential uses in the Community in 2008 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council (notified under document number C(2008) 1403) (Only the Danish, Dutch, English, Estonian, French, German, Italian, Slovenian and Spanish texts are authentic) (Text with EEA relevance) (2008/409/EC), Annex III: ESSENTIAL LABORATORY USES

Extent: E+W+S+N.I.

Quota of controlled substances of Groups I and II that may be used for laboratory and analytical uses, are allocated to:
Bie & Berntsen (DK)
Carlo Erba Reactifs-SDS (FR)
CNRS — Département Galilée (FR)
Harp International (UK)
Honeywell Specialty Chemicals (DE)
Ineos Fluor (UK)
LGC Standards (DE)
Mallinckrodt Baker (NL)
Merck KGaA (DE)
Mikro + Polo (SI)
Panreac Quimica (ES)
Sanolabor (SI)
Sigma Aldrich Chimie (FR)
Sigma Aldrich Company (UK)
Sigma Aldrich Logistik (DE)
Tazzetti Fluids (IT)
VWR ISAS (FR)

---
Source: https://www.legislation.gov.uk/eudn/2008/409/annex/III (the official version)
Page: https://openlegislation.uk/eu-decision-2008-409/annex-III
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.